Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Proposed framework for myofascial pain in older adults: precision geriatrics plus digital therapeutics

This abstract describes a proposed biopsychosocial framework, not a tested treatment: it combines precision geriatrics and digital therapeutics for myofascial pain syndrome in older adults and prioritizes non-pharmacological strategies and structured deprescribing. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The abstract links myofascial pain syndrome in older adults to chronic pain and functional decline, with age-related mechanisms proposed as amplifiers. [1]

  2. The abstract says geriatric guidelines discourage many common analgesics and that the proposed framework prioritizes non-pharmacological strategies and structured deprescribing. [1]

  3. The abstract describes precision geriatrics using tools such as ultrasonography and frailty indices to phenotype patients and tailor interventions. [1]

The source at a glance

Study type / format
Review proposing a framework (abstract only)
Population / context
Older adults with myofascial pain syndrome, as described in the abstract.
Summary based on
Study abstract
Original publication
April 16, 2026

Age-related mechanisms proposed for myofascial pain

The abstract states that myofascial pain syndrome in older adults contributes to chronic pain and functional decline. It attributes this to age-related pathophysiological challenges: geroscience principles such as sarcopenia, inflammaging and cellular senescence are said to converge into heightened central sensitization that amplifies pain. These are described as proposed mechanisms in a review, not as measured causes in patients.

Supporting source [1]

Why the review favors non-drug options in older adults

According to the abstract, traditional pharmacotherapy carries risks in this population because of polypharmacy and vulnerability to adverse effects, and geriatric guidelines discourage many common analgesics. The proposed framework therefore prioritizes non-pharmacological strategies and structured deprescribing. Digital therapeutics are meant to deliver evidence-based non-pharmacological interventions such as cognitive behavioral therapy and therapeutic exercise while overcoming access barriers.

Supporting source [1]

Precision geriatrics phenotyping in the proposed roadmap

The abstract says precision geriatrics uses multidimensional assessment tools, for example ultrasonography and frailty indices, to phenotype patients and tailor interventions. Interventions are to be geriatrically adapted and delivered by multidisciplinary teams. The review presents itself as synthesizing recent evidence into a roadmap for clinicians; the abstract reports no trial, sample, follow-up or outcome data, so the framework's benefits for function, independence and quality of life remain proposals.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. This is a proposed framework from a review, not a tested intervention, and the abstract reports no study design, sample, follow-up or outcome results.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Myofascial pain in older adults: a geroscience-informed framework integrating precision geriatrics and digital therapeutics.

Chang Zhu, Jie Xu, Yating Gong, Chaoyu Wang, Wenting Xu, Lijun Chen · doi.org · April 16, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    a significant contributor to chronic pain and
  2. Finding 2 ↑

    many common analgesics discouraged by geriatric guidelines
  3. Finding 3 ↑

    to phenotype patients and tailor interventions

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…